世界卫生组织报告赞誉中国结核病预防性治疗实践

Core Viewpoint - China's preventive treatment for tuberculosis has shown significant results, earning praise from the World Health Organization and providing a replicable "Chinese model" for global efforts [1] Group 1: Preventive Treatment Network - Since 2021, China has established a comprehensive preventive treatment network, increasing the number of treated individuals from 22,778 in 2021 to 87,034 in 2024, targeting key populations such as close contacts, students, and HIV-infected individuals [1] - The country has released multiple technical guidelines and set clear goals in the "National Tuberculosis Prevention and Control Plan (2024-2030)," aiming for a coverage rate of 60% for preventive treatment among close contacts by 2025 and 80% by 2030 [1] Group 2: Local Innovations and Treatment Optimization - China has implemented localized innovations based on WHO standards, utilizing tuberculin skin tests, tuberculosis antigen skin tests, and interferon-gamma release assays for infection detection [1] - Treatment regimens have been optimized, changing the isoniazid and rifapentine regimen to a bi-weekly schedule, alongside the development of domestic immunological agents and exploration of shorter treatment courses [1] Group 3: Collaborative Network and Monitoring System - A three-tiered collaborative network has been established, comprising disease control institutions, designated medical facilities, and grassroots healthcare institutions, ensuring comprehensive services from screening to follow-up [1] - A standardized monitoring system has been set up to track key indicators, providing scientific evidence for tuberculosis prevention and control efforts [1] Group 4: Global Contribution - Through systematic advancement in tuberculosis preventive treatment, China aims to contribute effectively to the global goal of ending tuberculosis epidemics, continuing to provide support and solutions [1]